ADMA Biologics (ADMA) Balance Sheet: Assets & Liabilities

ADMA Biologics (ADMA) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), ADMA Biologics reported total assets of $624.24M and total liabilities of $146.92M. Shareholders' equity was $477.32M, up 36.8% from $349.02M a year earlier. Total debt stood at $72.14M against $87.63M in cash and short-term investments, a net cash position of $15.49M. That puts debt-to-equity at 0.15, compared with 0.24 a year earlier.

ADMA Biologics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for ADMA Biologics, Inc. (ADMA) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	87.63	103.15	51.35	86.52	51.09	55.92	26.75	22.75	43.11
Cash & Short-Term Investments	87.63	103.15	51.35	86.52	51.09	55.92	26.75	22.75	43.11
Accounts Receivable	158.43	50.00	27.42	15.51	28.58	13.24	3.47	1.39	3.88
Inventory	206.47	170.24	172.91	163.28	124.72	81.54	53.06	18.62	12.63
Other Current Assets	7.46	8.03	5.33	5.10	4.34	3.05	2.53	3.53	3.28
Total Current Assets	466.51	331.41	257.01	270.40	208.73	153.74	85.82	44.53	63.17
Non-Current Assets
Property, Plant & Equipment (Net)	71.71	63.34	63.47	68.75	58.20	45.85	32.99	30.12	30.47
Goodwill	3.53	3.53	3.53	3.53	3.53	3.53	3.53	3.53	3.53
Intangible Assets	0.63	0.46	0.50	1.01	1.73	2.44	3.16	4.00	4.85
Other Non-Current Assets	8.60	5.66	4.67	4.77	4.07	2.11	1.60	6.70	6.01
Total Non-Current Assets	157.73	157.27	72.17	78.06	67.52	53.93	41.27	44.35	44.85
Total Assets	624.24	488.68	329.18	348.46	276.25	207.67	127.09	88.88	108.02
Current Liabilities
Accounts Payable	22.52	20.22	15.66	13.23	12.43	11.07	9.17	5.90	5.92
Short-Term Debt	2.81	2.44	1.05	0.91	0.59	0.37	0.23	0.03	0.00
Current Portion of Long-Term Debt	2.81	-	-	-	-	-	-	-	-
Accrued Liabilities	27.68	34.11	30.55	24.99	16.20	8.16	-	-	-
Deferred Revenue	0.00	0.14	0.18	0.14	0.14	0.14	0.14	0.14	0.14
Other Current Liabilities	6.82	29.26	2.37	1.80	1.01	0.21	4.48	3.55	3.38
Total Current Liabilities	69.54	55.54	49.81	39.27	30.38	19.95	14.03	9.63	9.44
Non-Current Liabilities
Long-Term Debt	69.33	80.90	130.59	144.33	94.87	92.97	84.50	44.19	42.97
Deferred Tax Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-40.53	0.00
Other Non-Current Liabilities	1.41	1.67	2.11	2.18	0.40	0.05	0.11	12.88	12.73
Total Non-Current Liabilities	77.38	84.12	144.17	157.22	104.70	99.48	86.87	59.48	58.25
Total Liabilities	146.92	139.66	193.98	196.49	135.08	119.42	100.90	69.11	67.69
Stockholders' Equity
Common Stock	0.02	0.02	0.02	0.02	0.02	0.01	0.01	0.00	0.00
Retained Earnings	-161.65	-308.58	-506.26	-478.02	-412.11	-340.47	-264.72	-216.44	-150.69
Accumulated Other Comprehensive Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-3.42	-1.29
Treasury Stock	32.09	-	-	-	-	-	-	-	-
Additional Paid-in Capital	671.04	657.58	641.44	629.97	553.27	428.70	290.90	236.20	191.02
Shares Outstanding	237.87	236.62	226.06	221.82	195.81	-	-	-	-
Total Stockholders' Equity	477.32	349.02	135.21	151.97	141.17	88.25	26.19	19.77	40.33
Total Liabilities & Equity	624.24	488.68	329.18	348.46	276.25	207.67	127.09	88.88	108.02

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About ADMA Biologics Balance Sheet

How much debt does ADMA Biologics have?

ADMA Biologics had total debt of $72.14M as of Dec 31, 2025, against $87.63M in cash and short-term investments. Its debt-to-equity ratio was 0.15. Total debt was $83.33M a year earlier.

What are ADMA Biologics's total assets?

ADMA Biologics reported total assets of $624.24M as of Dec 31, 2025, up 27.7% from $488.68M a year earlier. Total liabilities were $146.92M.

What is ADMA Biologics's shareholders' equity?

ADMA Biologics's shareholders' equity was $477.32M as of Dec 31, 2025, or about $2.01 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition